Jennifer Saggio, RN, MSN, CRNP, CPON
Locations: Main Hospital
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)
Skip to content
As a Nurse Practitioner for Neuroblastoma Developmental Therapeutics, my role is to coordinate care for children with recurrent/refractory neuroblastoma. I provide consultations to physicians, nurses and families in order to meet the complex needs of both hospitalized and ambulatory patients with neuroblastoma. I manage the care of patients on investigational trials both while here in Philadelphia and when they travel back to their home institutions in order to provide them with seamless, comprehensive care.
I especially enjoy the close bonds that I am able to develop with patients and families as I help them to navigate their journey through the cancer experience.
Over the 16 years that I have worked in pediatric oncology, I have learned to never let anything surprise me. Children have an amazing way of enjoying life even when dealing with a life-threatening illness. I am humbled by all that they have taught me and continue to teach me every day.
I have presented posters and lectures that focus on all aspects of neuroblastoma, from diagnosis through recurrence and investigational therapies. My research interests lie in neuroblastoma and the investigational treatment options available to this population of patients.
Certified Pediatric Oncology Nurse (CPON)Certified Registered Nurse Practitioner (CRNP)Pediatric Advanced Life Support (PALS)
RN - University of Pennsylvania School of Nursing, Philadelphia, PA
University of Pennsylvania Graduate degree in Pediatric Acute/Chronic Care NP Program, Philadelphia, PA
Neuroblastoma Nurse Practitioner
Targeted Radiotherapy for Neuroblastoma – presented at the Advances in Neuroblastoma Treatment Conference in Toronto, Canada
Targeted therapy for Neuroblastoma – focused on new pharmacologic agents being used for neuroblastoma treatment – presented at The Association of Pediatric Hematology/Oncology Nurses Annual Conference
Saggio J, Baniewicz D. Immunotherapy for neuroblastoma: how did we get here? Why are we doing it? What's on the horizon? [oral presentation]. The Association of Pediatric Hematology/Oncology Nurses 35th Annual Conference; Anaheim, CA
Association of Pediatric Hematology/Oncology Nurses
Oncology Nurses Society
Children's Oncology Group Nursing Discipline
2010-present, Journal of Pediatric Oncology Nursing Continuing Education Committee
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.